Table 2

Histopathologic and immunohistochemical characterization of tumors

Organ and tumor typeHistologyImmunohistochemistryMetastasesGeneration, sex, comment
Mammary gland 
    Adenocarcinoma Solid, comedo, trabecular growth pattern, single acinar/ductal structures, necrosis, grade 3 hVEGF-D positive in ductal part (surface); CD31, CD34, LYVE-1 negative in tumor cells − F1, male, left cervical mammary gland 
    Adenocarcinoma Solid, comedo growth pattern, necrosis hVEGF-D positive in ductal part; CK7 positive; CD31, CD34, LYVE-1 negative in tumor cells; increased number of vessels in tumor; angiogenic features − F3, female, left inguinal mammary gland, lactating, skin ulcerated 
Mammary gland preserved at the edge, grade 3 
    Adenocarcinoma Tubular, nestal, papillar, and trabecular growth pattern; necrosis hVEGF-D positive in ductal part (surface); CK7 positive; CD31, CD34, LYVE-1 negative in tumor cells; increased number of vessels in tumor; angiogenic features Lung metastases F1, female, right inguinal mammary gland 
Mammary gland preserved at the edge, grade 3 
    Adenocarcinoma Tubular growth pattern, in situ component,mammary gland largely preserved, grade 1 hVEGF-D positive in ductal part (surface); CD31, CD34, LYVE-1 negative in tumor cells; increased amount of vessels in tumor; angiogenic features − F1, female, right abdominal mammary gland 
Lung 
    Adenocarcinoma Multifocal, foci of bronchioloalveolar proliferation, grade 1 hVEGF-D negative − F1, female 
    Papillary adenocarcinoma Multifocal, papillary growth pattern, grade 1 hVEGF-D positive in stroma of papilla stalk; CD31, CD34, LYVE-1 negative in tumor cells − F1, male 
Skin 
    Basal cell carcinoma Predominantly solid growth of round basal cells, necrosis hVEGF-D negative; CD31, CD34, LYVE-1 negative in tumor cells − F3, female 
    Anaplastic carcinoma Solid infiltrative growth of spindle and round cells, necrosis, infiltrating soft tissues (muscle, bone) hVEGF-D positive in some tumor cells; CD31, CD34, LYVE-1 negative in tumor cells; increased amount of vessels in tumor; angiogenesis features − F1, male 
Organ and tumor typeHistologyImmunohistochemistryMetastasesGeneration, sex, comment
Mammary gland 
    Adenocarcinoma Solid, comedo, trabecular growth pattern, single acinar/ductal structures, necrosis, grade 3 hVEGF-D positive in ductal part (surface); CD31, CD34, LYVE-1 negative in tumor cells − F1, male, left cervical mammary gland 
    Adenocarcinoma Solid, comedo growth pattern, necrosis hVEGF-D positive in ductal part; CK7 positive; CD31, CD34, LYVE-1 negative in tumor cells; increased number of vessels in tumor; angiogenic features − F3, female, left inguinal mammary gland, lactating, skin ulcerated 
Mammary gland preserved at the edge, grade 3 
    Adenocarcinoma Tubular, nestal, papillar, and trabecular growth pattern; necrosis hVEGF-D positive in ductal part (surface); CK7 positive; CD31, CD34, LYVE-1 negative in tumor cells; increased number of vessels in tumor; angiogenic features Lung metastases F1, female, right inguinal mammary gland 
Mammary gland preserved at the edge, grade 3 
    Adenocarcinoma Tubular growth pattern, in situ component,mammary gland largely preserved, grade 1 hVEGF-D positive in ductal part (surface); CD31, CD34, LYVE-1 negative in tumor cells; increased amount of vessels in tumor; angiogenic features − F1, female, right abdominal mammary gland 
Lung 
    Adenocarcinoma Multifocal, foci of bronchioloalveolar proliferation, grade 1 hVEGF-D negative − F1, female 
    Papillary adenocarcinoma Multifocal, papillary growth pattern, grade 1 hVEGF-D positive in stroma of papilla stalk; CD31, CD34, LYVE-1 negative in tumor cells − F1, male 
Skin 
    Basal cell carcinoma Predominantly solid growth of round basal cells, necrosis hVEGF-D negative; CD31, CD34, LYVE-1 negative in tumor cells − F3, female 
    Anaplastic carcinoma Solid infiltrative growth of spindle and round cells, necrosis, infiltrating soft tissues (muscle, bone) hVEGF-D positive in some tumor cells; CD31, CD34, LYVE-1 negative in tumor cells; increased amount of vessels in tumor; angiogenesis features − F1, male 
Close Modal

or Create an Account

Close Modal
Close Modal